Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery through artificial intelligence.
The company said it was partnering with drugmakers AstraZeneca, Merck and Eli Lilly for its Billion Cell Atlas, which will train advanced AI models at scale and advance research into fundamental disease mechanisms that have previously been out of reach.
Drug developers are increasingly adopting AI for discovery and safety testing to get faster and cheaper results, in line with the U.S. Food and Drug Administration's push to reduce animal testing in the near future.
Drug development software maker Certara and biotechs such as Schrodinger and Recursion Pharmaceuticals are using the booming technology to predict how experimental drugs might be absorbed, distributed or trigger toxic side-effects.
"We believe the Cell Atlas is a key development that will enable us to significantly scale AI for drug discovery," said Illumina CEO Jacob Thaysen.
The Atlas will capture how 1 billion individual cells respond to genetic changes via CRISPR across more than 200 disease-relevant cell lines.
These cell lines have been selected for their relevance to diseases, many of which have been historically difficult to decode, including immune disorders and cancer as well as cardiometabolic, neurological and rare genetic diseases.
The Atlas will enable users to characterize drug and disease mechanisms of action, explore potential new indications and validate candidate targets from human genetics.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
latest_posts
- 1
'Fertiliser costs mean I'm better off not planting' - 2Dominating the Remote Work Way of life: Individual Systems
- 3Audits of Espresso Types: Which Mix Is for You?
- 4Historic underwater structure discovered by divers off French coast
- 57 Straightforward Moves toward Move Information from Your Old Cell phone to Your New One: A Thorough Aide
- Unsold Rams May Be Less expensive Than You Suspect
- The most effective method to Begin Your Excursion in Gold Venture
- Israel's ban on unsupervised reporters in Gaza causes strategic harm to legitimacy
- Ukrainian drones hit all three Baltic States − did Russia redirect them?
- Fascinating Fishing Objections From Around The World
- They died 'doing what they loved': The stories of workers in their 80s who died on the job
- Which Carrier Do You Suggest? Vote
- Nikki Glaser returns as host of the 2026 Golden Globes: Everything the comedian has said about the upcoming awards show
- Vote in favor of your Number one kind of juice
